R&D From reactive to predictive: How data is redefining pharma l... Pharmaceutical supply chains have more data at their fingertips than ever before. The challenge is turning that information into foresight.
Digital Monzo-meets-medicine? A prescription for just-in-time health... Challenger brand thinking has transformed industries all around us. What if we applied the same to healthcare?
Sales & Marketing HCP marketing’s Pharma 4.0 moment: Leveraging AI for real-ti... With healthcare marketing becoming more digital than ever, artificial intelligence (AI) for marketers has ceased to be merely a buzzword.
Patients On Pfizer’s initiative to return clinical trial data to pati... Among the most common reasons for dropping out, patients cite a lack of communication about the trial
Sales & Marketing Exploring the impact of patient flow forecasting on the pati... The primary goal of healthcare providers and pharmaceutical companies is to improve patient outcomes. Accurate patient flow forecasting is critical in achieving this objective.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.